Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Intervention group:therapeutic monoclonal antibodies
Sponsors
The Third People's Hospital of Shenzhen
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. At least 18 years of age; 2. Within 7 days of screening, SARS-CoV-2 infection is clearly identified by PCR testing; 3. Male or female (contraceptive or infertile).
Exclusion criteria
Exclusion criteria: 1. Patients with COVID-19 recurrence; 2. When screening, meet any of the following: (1) Stroke; (2) Meningitis; (3) Encephalitis; (4) Myelitis; (5) Myocardial ischemia; (6) Myocarditis; (7) Pericarditis; (8) Congestive heart failure (NYHA class III-IV); (9) Arterial or deep vein thrombosis, pulmonary embolism; 3. Have a history of severe allergic reactions, including systemic urticaria, angioedema, hypersensitivity reactions; 4. Chronic active liver disease; 5. Have received COVID-19 convalescence plasma and SARS-CoV-2 antibody treatment; 6. Have received other investigational drugs for the treatment of SARS-CoV-2; 7. The history of drug abuse within 1 year before screening; 8. The research doctor judges that there is any situation that is not suitable for participating in the project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SARS-CoV-2 RNA quantification; | — |
Countries
China
Contacts
Public ContactZhang Zheng
The Third People's Hospital of Shenzhen
Outcome results
None listed